Shanghai RAAS Blood Products Co Ltd Class A (002252) - Total Assets

Latest as of September 2025: CN¥38.02 Billion CNY ≈ $5.56 Billion USD

Based on the latest financial reports, Shanghai RAAS Blood Products Co Ltd Class A (002252) holds total assets worth CN¥38.02 Billion CNY (≈ $5.56 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 002252 net asset value for net asset value and shareholders' equity analysis.

Shanghai RAAS Blood Products Co Ltd Class A - Total Assets Trend (2005–2024)

This chart illustrates how Shanghai RAAS Blood Products Co Ltd Class A's total assets have evolved over time, based on quarterly financial data.

Shanghai RAAS Blood Products Co Ltd Class A - Asset Composition Analysis

Current Asset Composition (December 2024)

Shanghai RAAS Blood Products Co Ltd Class A's total assets of CN¥38.02 Billion consist of 27.5% current assets and 72.5% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	8.9%
Accounts Receivable	CN¥1.81 Billion	5.4%
Inventory	CN¥4.29 Billion	12.8%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥485.01 Million	1.4%
Goodwill	CN¥5.07 Billion	15.1%

Asset Composition Trend (2005–2024)

This chart illustrates how Shanghai RAAS Blood Products Co Ltd Class A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Shanghai RAAS Blood Products Co Ltd Clas market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Shanghai RAAS Blood Products Co Ltd Class A's current assets represent 27.5% of total assets in 2024, a decrease from 73.8% in 2005.
Cash Position: Cash and equivalents constituted 8.9% of total assets in 2024, up from 6.8% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 0.0% in 2005.
Asset Diversification: The largest asset category is goodwill at 15.1% of total assets.

Shanghai RAAS Blood Products Co Ltd Class A Competitors by Total Assets

Key competitors of Shanghai RAAS Blood Products Co Ltd Class A based on total assets are shown below.

Company	Country	Total Assets
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$7.59 Billion
Summit Therapeutics PLC NASDAQ:SMMT	USA	$261.73 Million
Argen-X F:1AE	Germany	€7.18 Billion
Metsera, Inc. Common Stock NASDAQ:MTSR	USA	$639.66 Million
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	China	CN¥3.06 Billion
R&G PharmaStudies Co. Ltd. A SHE:301333	China	CN¥2.31 Billion
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	China	CN¥819.45 Million
Innovita Biological Technology Co. Ltd. A SHG:688253	China	CN¥2.16 Billion

Shanghai RAAS Blood Products Co Ltd Class A - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.37	4.21	15.18
Quick Ratio	1.77	2.41	8.63
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥6.87 Billion	CN¥6.93 Billion	CN¥4.68 Billion

Shanghai RAAS Blood Products Co Ltd Class A - Advanced Valuation Insights

This section examines the relationship between Shanghai RAAS Blood Products Co Ltd Class A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.28
Latest Market Cap to Assets Ratio	0.16
Asset Growth Rate (YoY)	5.3%
Total Assets	CN¥33.63 Billion
Market Capitalization	$5.40 Billion USD

Valuation Analysis

Below Book Valuation: The market values Shanghai RAAS Blood Products Co Ltd Class A's assets below their book value (0.16x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Shanghai RAAS Blood Products Co Ltd Class A's assets grew by 5.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Shanghai RAAS Blood Products Co Ltd Class A (2005–2024)

The table below shows the annual total assets of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥33.63 Billion ≈ $4.92 Billion	+5.33%
2023-12-31	CN¥31.93 Billion ≈ $4.67 Billion	+4.83%
2022-12-31	CN¥30.46 Billion ≈ $4.46 Billion	+11.83%
2021-12-31	CN¥27.24 Billion ≈ $3.99 Billion	+6.84%
2020-12-31	CN¥25.49 Billion ≈ $3.73 Billion	+115.08%
2019-12-31	CN¥11.85 Billion ≈ $1.73 Billion	+4.09%
2018-12-31	CN¥11.39 Billion ≈ $1.67 Billion	-21.22%
2017-12-31	CN¥14.46 Billion ≈ $2.12 Billion	+9.30%
2016-12-31	CN¥13.23 Billion ≈ $1.94 Billion	+14.45%
2015-12-31	CN¥11.56 Billion ≈ $1.69 Billion	+23.21%
2014-12-31	CN¥9.38 Billion ≈ $1.37 Billion	+495.47%
2013-12-31	CN¥1.58 Billion ≈ $230.49 Million	+30.36%
2012-12-31	CN¥1.21 Billion ≈ $176.81 Million	+19.69%
2011-12-31	CN¥1.01 Billion ≈ $147.73 Million	+8.51%
2010-12-31	CN¥930.33 Million ≈ $136.14 Million	+12.74%
2009-12-31	CN¥825.22 Million ≈ $120.76 Million	-0.72%
2008-12-31	CN¥831.19 Million ≈ $121.63 Million	+171.15%
2007-12-31	CN¥306.54 Million ≈ $44.86 Million	-5.73%
2006-12-31	CN¥325.16 Million ≈ $47.58 Million	-2.54%
2005-12-31	CN¥333.63 Million ≈ $48.82 Million	--

About Shanghai RAAS Blood Products Co Ltd Class A

SHE:002252 China Biotechnology

Market Cap

$5.40 Billion

CN¥36.91 Billion CNY

Market Cap Rank

#3402 Global

#515 in China

Share Price

CN¥5.56

Change (1 day)

+0.18%

52-Week Range

CN¥5.47 - CN¥7.18

All Time High

CN¥24.72